Serum TSH and the response to radioiodine treatment of toxic multinodular goitre

European Journal of Endocrinology

Volumn 137, Issue 4, 1997, Pages 365-369

  Pedersen Bjergaard, Ulrik ^a   Kirkegaard, Carsten ^a  

^a HILLERØD HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

IODINE 131; THYROTROPIN;

ADULT; ARTICLE; FEMALE; HUMAN; HYPOTHYROIDISM; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE; RADIOISOTOPE THERAPY; THYROID WEIGHT; THYROTROPIN BLOOD LEVEL; TOXIC GOITER; TREATMENT FAILURE;

FEMALE; GOITER, NODULAR; HUMANS; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; OSMOLAR CONCENTRATION; RETREATMENT; THYROTROPIN; TREATMENT OUTCOME;

EID: 0030882498     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1370365     Document Type: Article

References (16)

1. Klein I, Becker DV & Levey GS. Treatment of hyperthyroid disease. Annals of Internal Medicine 1994 121 281-288.
2. Franklyn JA. The management of hyperthyroidism. New England Journal of Medicine 1994 330 1731-1738.
3. Hegedüs L & Faber J. Calculation of the ideal dose of radioiodine for treatment of thyroid disease. European Journal of Endocrinology 1995 132 544-545.
4. 131I treatment of diffuse and nodular toxic goitre with or without antithyroid agents. Acta Endocrinologica 1982 99 517-521.
5. Ross DS, Chester Ridgway E & Daniels GH. Successful treatment of solitary toxic thyroid nodules with relatively low-dose iodine-131, with low prevalence of hypothyroidism. Annals of Internal Medicine 1984 101 488-490.
6. 131I-therapy of solitary autonomous thyroid nodules: effect on thyroid size and early hypothyroidism. Acta Endocrinologica 1986 113 226-232.
7. Kinser JA, Roesler H, Furrer T, Grütter D & Zimmermann H. Nonimmunogenic hyperthyroidism: cumulative hypothyroidism incidence after radioiodine and surgical treatment. Journal of Nuclear Medicine 1989 30 1960-1965.
8. Franklyn JA, Daykin J, Droic Z, Farmer M & Sheppard MC. Long-term follow-up of treatment of thyrotoxicosis by three different methods. Clinical Endocrinology 1991 34 71-76.
9. Reinhardt M, Emrich D, Krause T, Bräutigam P, Nitzsche E, Blattmann H, Schümichen C & Moser E. Improved dose concept for radioiodine therapy of multifocal and disseminated functional thyroid autonomy. European Journal of Endocrinology 1995 132 550-556.
10. Berg G, Michanek A, Holmberg E & Nyström E. Clinical outcome of radioiodine treatment of hyperthyroidism: a follow-up study. Journal of Internal Medicine 1996 239 165-171.
11. Jarløv AE, Hegedüs L, Kristensen LØ, Nygaard B & Hansen JM. Is calculation of the dose in radioiodine therapy of hyperthyroidism worth while? Clinical Endocrinology 1995 43 325-329.
12. Berg GEB, Michanek AMK, Holmberg ECV & Fink M. Iodine-131 treatment of hyperthyroidism: significance of effective half-life measurements. Journal of Nuclear Medicine 1996 37 228-232.
13. Clerc J, Dagousset F, Izembart M, Jais J-P, Heshmati HM, Alcaïs A, Chevalier A, Léger AF & Barritault L. Radioiodine therapy of the autonomous thyroid nodule in patients with or without visible extranodular activity. Journal of Nuclear Medicine 1995 36 217-223.
14. Velkeniers B, Cytryn R, Vanhaelst L & Jonckheer MH. Treatment of hyperthyroidism with radioiodine: adjunctive therapy with antithyroid drugs reconsidered. Lancet 1988 i 1127-1129.
15. 131I therapy for 2000 thyrotoxic patients: do the effects depend on the dose? Experimental and Clinical Endocrinology 1991 97 286-291.
16. Jarløv AE, Hegedüs L, Gjørup T & Hansen JM. Observer variation in the clinical assessment of the thyroid gland. Journal of Internal Medicine 1991 229 159-161.